Provectus Biopharmaceuticals (PVCT) Interest & Investment Income (2010 - 2021)
Provectus Biopharmaceuticals (PVCT) posted Interest & Investment Income of $2.00 for Q4 2021, up 100.0% from $1.00 a year earlier and up 100.0% from the prior quarter.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) Interest & Investment Income (2010 - 2021) Analysis & Trends
For FY2021, Provectus Biopharmaceuticals' Interest & Investment Income came in at $4.00, down 99.9% from FY2020.
- Annual Interest & Investment Income shows a five-year compound annual growth rate of -71.5% (FY2016 to FY2021).
- In prior years, Provectus Biopharmaceuticals' Interest & Investment Income was $3,415 in FY2020 (-85.3%), $23,162 in FY2019 (+18.4%), $19,560 in FY2018 (-37.5%) and $31,304 in FY2017.
- The Q4 2021 figure stands as the highest quarterly Interest & Investment Income since Q3 2020.
- On a year-over-year basis, Interest & Investment Income increased in 1 of the last seven quarters, with an average decline of 57.9%.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q2 2017, with growth of 971.0%; the weakest was Q3 2021, with a decline of 99.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | - |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | - |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 2.00 |
| Sep 30, 2021 | 1.00 |
| Mar 31, 2021 | 1.00 |
| Dec 31, 2020 | 1.00 |
| Sep 30, 2020 | 823.00 |
| Jun 30, 2020 | 3,334.00 |
| Mar 31, 2020 | 79.00 |
| Dec 31, 2019 | 117.00 |
| Sep 30, 2019 | 1,140.00 |
| Jun 30, 2019 | 19,650.00 |
| Mar 31, 2019 | 2,255.00 |
| Dec 31, 2018 | 2,904.00 |
| Sep 30, 2018 | 4,931.00 |
| Jun 30, 2018 | 5,556.00 |
| Mar 31, 2018 | 6,169.00 |
| Dec 31, 2017 | 7,043.00 |
| Sep 30, 2017 | 7,511.00 |
| Jun 30, 2017 | 8,075.00 |
| Mar 31, 2017 | 8,675.00 |
| Dec 31, 2016 | 141.00 |
API Access
Provectus Biopharmaceuticals Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();